Bionoid Pharma to Acquire AiMaverickIntel.com
Summary
Bionoid Pharma (OTC Pink: BINP), a Toronto, Canada-based bio-research company, announced is to acquire AiMaverickIntel.com, a Dallas, Texas-based provider of an audience acquisition platform empowered by artificial intelligence (AI). By integrating AiMaverickIntel.com’s capabilities, BINP aims to achieve substantial improvements in customer engagement and acquisition metrics. AiMaverickIntel.com offers a platform that helps companies identify, reach, and engage their target audience segments. Its advanced algorithms and machine learning capabilities provide actionable insights and optimize customer acquisition processes. According to a press release, this new agreement follows the cancellation of a previously announced agreement to acquire Global Alerts Corp. As detailed in a prior release, Bionoid Pharma signed a binding letter of intent to acquire Global Alerts Corp., however strategic considerations led the company to pursue the acquisition of AiMaverickIntel.com instead.